SEC Form D private-offering filing
REGENTIS BIOMATERIALS LTD.
A new SEC Form D private-offering notice from Herzliya, a $6,500,000 filer-stated offering target in Biotech. The source filing is one click away.
Israeli developer of Gelrin, a degradable hydrogel implant platform for orthopedic tissue repair, whose lead product GelrinC treats knee cartilage injuries.
Filed 2026-06-25Filed to raise $6,500,000First money in 2026-06-17Raised so far $6,500,000HQ (as filed) HerzliyaSector Biotech ✓Stage (inferred) EarlyCall status Non-US principal office
Source linked the Form D on EDGAR↗Website verified regentis.co.il↗Named in the filing 9 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.